US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

First Trust NYSE Arca Biotechnology Index Fund

264.97

-5.9600-2.20%

Post-market: 264.970.00000.00%16:15 EDT

Volume:71.46K

Turnover:18.95M

Market Cap:2.90B

PE:31.01

High:273.10

Open:273.10

Low:262.30

Close:270.93

52wk High:275.23

52wk Low:182.08

Shares:10.95M

Float Shares:10.95M

Volume Ratio:1.06

T/O Rate:0.65%

Dividend:- -

Dividend Rate:- -

EPS(TTM):8.55

EPS(LYR):37.75

ROE:19.96%

ROA:-0.16%

PB:1.04

PE(LYR):7.02

Loading ...

Overview Company News Filings

Corcept Therapeutics (CORT) Stock Could Be Undervalued Despite Mixed Broader Checks

Simply Wall St.

Deltic Energy sets remote court hearing as NEO NEXT+ cash takeover nears completion

Circio’s circVec gene therapy platform secures oral slot at top European ESGCT conference

How NeoGenomics’ Q2 Profit Return And Higher 2026 Outlook At NeoGenomics (NEO) Has Changed Its Investment Story

Simply Wall St.

Corcept Chief Accounting & Technology Officer Joseph Douglas Lyon Disposes of 1,540 Common Shares Worth $175,806.40

Wall Street Analysts Are Bullish on Top Healthcare Picks

Bruker (BRKR) Receives a Buy from Wells Fargo

Bruker Corporation : Stifel Raises Target Price to $50 from $45

THOMSON REUTERS

Bruker Corporation : Leerink Partners Cuts Target Price to $60 from $70

THOMSON REUTERS

Bruker (BRKR) Stock Price Sinks After Goodwill Hit Triggers Loss

Simply Wall St.

Bruker Down Nearly 20%, on Track for Largest Percent Decrease Since December 2008

Bruker falls -18.4%

Bruker Corp Reports Results for the Quarter Ended June 30 - Earnings Summary

Bruker Q2 GAAP Diluted Loss Widens to $(0.41) Per Share; Revenue Rises 5.2% to $838.5 Million Year-over-Year

Bruker Q2 Adjusted EPS USD 0.49 Vs. IBES Estimate USD 0.38

Bruker Q2 Net Income USD -50.9 Million

THOMSON REUTERS

Bruker Q2 Operating Expenses USD 481.3 Million

THOMSON REUTERS

Bruker Outlook FY Revenue USD 3,540-3,570 Million VS. Ibes Estimate USD 3,589 Million

THOMSON REUTERS

Bruker Q2 Gross Profit USD 416 Million

THOMSON REUTERS

Alkermes EVP, CLO David Joseph Gaffin Sells 2,034 Shares for $98,821.72

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg1.tigeractivity.com/stock/FBT/news?page=9"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"FBT","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FBT\",,,,,undefined,":{"symbol":"FBT","market":"US","secType":"STK","nameCN":"First Trust NYSE Arca Biotechnology Index Fund","latestPrice":264.97,"timestamp":1791316800000,"preClose":270.93,"halted":0,"volume":71461,"hourTrading":{"tag":"盘后","latestPrice":264.97,"preClose":264.97,"latestTime":"16:15 EDT","volume":14,"amount":3709.5800000000004,"timestamp":1791317700457,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.021998302144465284,"floatShares":10950002,"shares":10950002,"eps":8.545272,"marketStatus":"Post-Mkt","change":-5.96,"latestTime":"10-06 17:30:50 EDT","open":273.1,"high":273.1,"low":262.3,"amount":18951348,"amplitude":0.039863,"askPrice":276.77,"askSize":2,"bidPrice":239.88,"bidSize":100,"shortable":3,"etf":1,"ttmEps":8.545272,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1791331200000},"marketStatusCode":4,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":270.93,"sharesOutstanding":11450002,"nav":266.33,"aum":2902997532.66,"bidAskSpread":0.000914,"preHourTrading":{"tag":"盘前","latestPrice":270.93,"preClose":270.93,"latestTime":"08:11 EDT","volume":4,"amount":1082.099,"timestamp":1791288685408,"change":0,"changeRate":0,"amplitude":0.007238},"postHourTrading":{"tag":"盘后","latestPrice":264.97,"preClose":264.97,"latestTime":"16:15 EDT","volume":14,"amount":3709.5800000000004,"timestamp":1791317700457,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.057976,"impliedVol":0.2498,"impliedVolPercentile":0.9203},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FBT\",,,,,undefined,":{"symbol":"FBT","floatShares":10950002,"roa":"-0.16%","roe":"19.96%","lyrEps":37.754725,"volumeRatio":1.057976,"shares":10950002,"dividePrice":0,"high":273.1,"amplitude":0.039863,"preClose":270.93,"low":262.3,"week52Low":182.08,"pbRate":"1.04","psRate":"699.94","week52High":275.23,"institutionHeld":0,"latestPrice":264.97,"committee":0.960784,"eps":8.545272,"divideRate":0,"volume":71461,"delay":0,"ttmEps":8.545272,"open":273.1,"prevYearClose":206.52,"prevWeekClose":266.44,"prevMonthClose":272.26,"prevQuarterClose":272.26,"fiveDayClose":272.58,"twentyDayClose":265.78,"sixtyDayClose":247.54},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/FBT\",params:#limit:5,,,undefined,":[{"date":"2024-12-13","symbol":"FBT","amount":1.1726,"announcedDate":"2024-12-12","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-13","defaultRemindTime":1734100200000,"name":"First Trust NYSE Arca Biotechnology Index Fund","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-31","payableDate":"2024-12-13","currency":"USD","dateTimestamp":1734066000000,"payDate":"2024-12-31"},{"market":"US","date":"2022-01-10","symbol":"FBT","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1641790800000,"reportTimeType":"","actualEps":null},{"market":"US","date":"2021-12-30","symbol":"FBT","amount":2.2136,"defaultRemindTime":1640874600000,"name":"First Trust NYSE Arca Biotechnology Index Fund","recordDate":"2022-01-10","payableDate":"2021-12-31","currency":"USD","type":"dividend","dateTimestamp":1640840400000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"FBT\",market:\"US\",,,undefined,":[{"executeDate":"2021-12-30","recordDate":"2021-12-31","paymentDate":"2022-01-10","value":2.2136,"currency":"USD"},{"executeDate":"2024-12-13","recordDate":"2024-12-13","paymentDate":"2024-12-31","value":1.1726,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"FBT\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"FBT\",pageSize:20,pageCount:9,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2657656597","title":"Corcept Therapeutics (CORT) Stock Could Be Undervalued Despite Mixed Broader Checks","url":"https://stock-news.laohu8.com/highlight/detail?id=2657656597","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657656597?lang=en_us&edition=fundamental","pubTime":"2026-08-06 23:39","pubTimestamp":1786030757,"startTime":"0","endTime":"0","summary":"Corcept Therapeutics stock has delivered a very large 5 year return, yet its recent valuation checks suggest the shares are not an obvious bargain at today's level.\n\nOver the past 5 years, Corcept Therapeutics has returned about 4.4x, which sets a high bar for any further upside to be justified by fundamentals.\nInvestor focus is currently on how demand for the company’s treatments and late stage pipeline can support future revenue, while execution and clinical outcomes across those programs...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-cort/corcept-therapeutics/news/corcept-therapeutics-cort-stock-could-be-undervalued-despite","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-cort/corcept-therapeutics/news/corcept-therapeutics-cort-stock-could-be-undervalued-despite","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["PSCH","LU0566484027.USD","LU1559883803.SGD","FBT","BK4007","CORT","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657020325","title":"Deltic Energy sets remote court hearing as NEO NEXT+ cash takeover nears completion","url":"https://stock-news.laohu8.com/highlight/detail?id=2657020325","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657020325?lang=en_us&edition=fundamental","pubTime":"2026-08-06 14:12","pubTimestamp":1785996756,"startTime":"0","endTime":"0","summary":"Deltic Energy ( ($GB:DELT) ) has shared an announcement. Deltic Energy and NEO NEXT+ Energy Upstream UK have confirmed progress on NEO NEXT+’s reco...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/deltic-energy-sets-remote-court-hearing-as-neo-next-cash-takeover-nears-completion?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/deltic-energy-sets-remote-court-hearing-as-neo-next-cash-takeover-nears-completion?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4144","NEO","BK4121","LU0012050646.USD","LU0106261612.USD","NEXT","FBT","BESF","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657023575","title":"Circio’s circVec gene therapy platform secures oral slot at top European ESGCT conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2657023575","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657023575?lang=en_us&edition=fundamental","pubTime":"2026-08-06 13:45","pubTimestamp":1785995139,"startTime":"0","endTime":"0","summary":"Targovax ASA ( ($GB:0RIS) ) has shared an announcement. Circio Holding ASA, a biotechnology company specializing in circular RNA expression systems...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/circios-circvec-gene-therapy-platform-secures-oral-slot-at-top-european-esgct-conference?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/circios-circvec-gene-therapy-platform-secures-oral-slot-at-top-european-esgct-conference?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CNCR","AGNG","IE0009354923.USD","FHLC","SYNB","BK4139","FBT","GNOM","EPV","LNGR","RNA","BK4505","LFSC","FWD","IEIH","TBXU","IBB","IBBQ","DARP","XT","RSPH","BK4588","BK4585","JDOC","RDMX","BBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657509379","title":"How NeoGenomics’ Q2 Profit Return And Higher 2026 Outlook At NeoGenomics (NEO) Has Changed Its Investment Story","url":"https://stock-news.laohu8.com/highlight/detail?id=2657509379","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657509379?lang=en_us&edition=fundamental","pubTime":"2026-08-06 11:41","pubTimestamp":1785987715,"startTime":"0","endTime":"0","summary":"In late July 2026, NeoGenomics reported second-quarter 2026 results showing sales of US$201.66 million and a return to profitability with net income of US$2.24 million, alongside higher first-half revenue and a sharply reduced year-to-date net loss.\nThe company also raised its full-year 2026 revenue outlook to US$802 million–US$806 million and tightened its projected net loss range, which points to improving operating performance and greater confidence in its business trajectory.\nNext, we’ll...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/9551728-choice2-main-header/1585186774276","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551728-choice2-main-header/1585186774276"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nasdaq-neo/neogenomics/news/how-neogenomics-q2-profit-return-and-higher-2026-outlook-at","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-neo/neogenomics/news/how-neogenomics-q2-profit-return-and-higher-2026-outlook-at","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU0012050646.USD","FBT","BK4121","BK4196","NEO","LU0106261612.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657571260","title":"Corcept Chief Accounting & Technology Officer Joseph Douglas Lyon Disposes of 1,540 Common Shares Worth $175,806.40","url":"https://stock-news.laohu8.com/highlight/detail?id=2657571260","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657571260?lang=en_us&edition=fundamental","pubTime":"2026-08-06 06:11","pubTimestamp":1785967865,"startTime":"0","endTime":"0","summary":"Corcept Chief Accounting & Technology Officer Joseph Douglas Lyon disposes of 1,540 common shares worth $175,806.40Corcept Therapeutics Chief Accounting & Technology Officer Joseph Douglas Lyon sold 1","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nNDL4ffvrh:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Corcept Chief Accounting & Technology Officer Joseph Douglas Lyon Disposes of 1,540 Common Shares Worth $175,806.40","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1559883803.SGD","BK4532","BK4007","LU0566484027.USD","PSCH","FBT","CORT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657256541","title":"Wall Street Analysts Are Bullish on Top Healthcare Picks","url":"https://stock-news.laohu8.com/highlight/detail?id=2657256541","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657256541?lang=en_us&edition=fundamental","pubTime":"2026-08-05 20:01","pubTimestamp":1785931309,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on IDEAYA Biosciences (IDYA), Bruker (BRKR) and Rhythm ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-277?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-277?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BRKR","BK4139","BK4121","LU0757428866.USD","IDYA","FBT","TINY","LU1815336091.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657417615","title":"Bruker (BRKR) Receives a Buy from Wells Fargo","url":"https://stock-news.laohu8.com/highlight/detail?id=2657417615","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657417615?lang=en_us&edition=fundamental","pubTime":"2026-08-05 19:50","pubTimestamp":1785930642,"startTime":"0","endTime":"0","summary":"Wells Fargo analyst maintained a Buy rating on Bruker today and set a price target of $55.00. Bruker has an analyst consensus of Moderate Buy, with...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/bruker-brkr-receives-a-buy-from-wells-fargo-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/bruker-brkr-receives-a-buy-from-wells-fargo-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0310800379.SGD","LU0942090050.USD","LU0106831901.USD","LU0130517989.USD","LU0149725797.USD","LU1074936037.SGD","LU0640476718.USD","LU1267930573.SGD","LU2361045086.USD","TFNS","IE00B19Z3B42.SGD","IYF","PGF","LU0787776722.HKD","BK4504","LU0289960550.SGD","KBWB","FTXO","LU1894683264.USD","LU1267930490.SGD","LU0029864427.USD","LU0052756011.USD","LU1815336091.USD","LU0211327993.USD","LU0211328371.USD","LU0072461881.USD","LU1363072403.SGD","BRKR","LU0070302665.USD","LU0251131958.USD","IE00B19Z3581.USD","LU0742534661.SGD","LU1201861249.SGD","LU1668664300.SGD","BK4207","LU0708994859.HKD","LU0256863811.USD","LU1035773651.USD","IE0002270589.USD","LU0251142724.SGD","LU0683600562.USD","LU1069347547.HKD","LU0320765489.SGD","LU0971096721.USD","IE000M9KFDE8.USD","LU0267386448.USD","LU0314106906.USD","LU0310800965.SGD","FBT","TINY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657546991","title":"Bruker Corporation : Stifel Raises Target Price to $50 from $45","url":"https://stock-news.laohu8.com/highlight/detail?id=2657546991","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657546991?lang=en_us&edition=fundamental","pubTime":"2026-08-05 19:11","pubTimestamp":1785928286,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nFWN4421BW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["FBT","LU1815336091.USD","LU0757428866.USD","BK4121","BRKR","TINY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657040592","title":"Bruker Corporation : Leerink Partners Cuts Target Price to $60 from $70","url":"https://stock-news.laohu8.com/highlight/detail?id=2657040592","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657040592?lang=en_us&edition=fundamental","pubTime":"2026-08-05 12:40","pubTimestamp":1785904848,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nFWN44204O:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BRKR","FBT","TINY","BK4121","LU0757428866.USD","LU1815336091.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657019593","title":"Bruker (BRKR) Stock Price Sinks After Goodwill Hit Triggers Loss","url":"https://stock-news.laohu8.com/highlight/detail?id=2657019593","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657019593?lang=en_us&edition=fundamental","pubTime":"2026-08-05 07:41","pubTimestamp":1785886889,"startTime":"0","endTime":"0","summary":"Bruker went into this earnings print looking like a mispriced quality story, then the stock dropped 22% in a single session and shattered that calm narrative. The result that really hit investors was not the modest revenue of US$838.5m. It was the swing back into a quarterly loss, with basic earnings per share at a loss of US$0.41, driven by a US$135m non cash goodwill impairment.\nThe stock may now appear cheaper on paper, but it also presents a more complicated profit story to assess. The...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-brkr/bruker/news/bruker-brkr-stock-price-sinks-after-goodwill-hit-triggers-lo","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-brkr/bruker/news/bruker-brkr-stock-price-sinks-after-goodwill-hit-triggers-lo","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU1815336091.USD","LU0757428866.USD","BRKR","TINY","BK4121","FBT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657356343","title":"Bruker Down Nearly 20%, on Track for Largest Percent Decrease Since December 2008","url":"https://stock-news.laohu8.com/highlight/detail?id=2657356343","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657356343?lang=en_us&edition=fundamental","pubTime":"2026-08-05 02:03","pubTimestamp":1785866580,"startTime":"0","endTime":"0","summary":"Bruker Corporation  is currently at $51.46, down $12.86 or 19.99%--Would be lowest close since May 27, 2026, when it closed at $48.62--On pace for largest percent decrease since Dec. 1, 2008, when it fell 20.64%--Currently down three of the past five days--Up 9.22% year-to-date--Down 45.42% from its all-time closing high of $94.27 on March 21, 2024--Up 60.45% from 52 weeks ago , when it closed at $32.07--Down 20.03% from its 52-week closing high of $64.34 on July 30, 2026--Up 75.32% from its 52-week closing low of $29.35 on Sept. 3, 2025--Traded as low as $51.25; lowest intraday level since May 28, 2026, when it hit $48.95--Down 20.31% at today's intraday low; largest intraday percent decrease since July 24, 2012, when it fell as much as 25.82%All data as of 2:01:05 PM ETSource: Dow Jones Market Data, FactSet","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1815336091.USD","BK4121","TINY","LU0757428866.USD","BRKR","FBT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656965554","title":"Bruker falls -18.4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2656965554","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656965554?lang=en_us&edition=fundamental","pubTime":"2026-08-04 22:00","pubTimestamp":1785852028,"startTime":"0","endTime":"0","summary":"Bruker (BRKR) is down -18.4%, or -$11.85 to $52.47. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/bruker-falls-18-4-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/bruker-falls-18-4-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BRKR","BK4121","LU0757428866.USD","FBT","TINY","LU1815336091.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656551985","title":"Bruker Corp Reports Results for the Quarter Ended June 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2656551985","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656551985?lang=en_us&edition=fundamental","pubTime":"2026-08-04 21:31","pubTimestamp":1785850306,"startTime":"0","endTime":"0","summary":"Bruker Corp reports results for the quarter ended June 30 - Earnings SummaryBruker CorpBRKR.OQreported quarterly adjusted earnings of 49 cents per share for the quarter ended June 30, higher than the ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260804:nL8N4411QJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1815336091.USD","BK4121","TINY","LU0757428866.USD","BRKR","FBT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656301065","title":"Bruker Q2 GAAP Diluted Loss Widens to $(0.41) Per Share; Revenue Rises 5.2% to $838.5 Million Year-over-Year","url":"https://stock-news.laohu8.com/highlight/detail?id=2656301065","media":"Reuters","labels":["event","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656301065?lang=en_us&edition=fundamental","pubTime":"2026-08-04 19:05","pubTimestamp":1785841542,"startTime":"0","endTime":"0","summary":"Bruker Q2 GAAP diluted loss widens to $(0.41) per share; revenue rises 5.2% to $838.5 million year-over-yearBruker Q2 2026 revenue rose 5.2% year-over-year to USD 838.5 million; GAAP diluted EPS turne","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260804:nNDLbJt55w:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"event,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","LU1815336091.USD","LU0757428866.USD","BRKR","FBT","TINY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656698530","title":"Bruker Q2 Adjusted EPS USD 0.49 Vs. IBES Estimate USD 0.38","url":"https://stock-news.laohu8.com/highlight/detail?id=2656698530","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656698530?lang=en_us&edition=fundamental","pubTime":"2026-08-04 19:01","pubTimestamp":1785841261,"startTime":"0","endTime":"0","summary":"BRIEF-Bruker Q2 Adjusted EPS USD 0.49 Vs. IBES Estimate USD 0.38Aug 04  - Bruker Q2 gross profit USD 416 million.Q2 operating income USD -65.3 millionQ2 operating expenses USD 481.3 millionQ2 net income USD -50.9 millionQ2 revenue USD 838.5 million vs. IBES estimate USD 853.5 millionoutlook FY revenue USD 3,540-3,570 million vs. IBES estimate USD 3,589 millionoutlook FY adjusted EPS USD 2.1-2.15 vs. IBES estimate USD 2.12","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260804:nPLX77K9ZM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","LU0757428866.USD","FBT","TINY","BRKR","LU1815336091.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656530354","title":"Bruker Q2 Net Income USD -50.9 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2656530354","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656530354?lang=en_us&edition=fundamental","pubTime":"2026-08-04 19:00","pubTimestamp":1785841201,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260804:nPLX77K9ZM:7","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1815336091.USD","BK4121","BRKR","FBT","LU0757428866.USD","TINY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656530347","title":"Bruker Q2 Operating Expenses USD 481.3 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2656530347","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656530347?lang=en_us&edition=fundamental","pubTime":"2026-08-04 19:00","pubTimestamp":1785841201,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260804:nPLX77K9ZM:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TINY","FBT","LU1815336091.USD","BRKR","LU0757428866.USD","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656530301","title":"Bruker Outlook FY Revenue USD 3,540-3,570 Million VS. Ibes Estimate USD 3,589 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2656530301","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656530301?lang=en_us&edition=fundamental","pubTime":"2026-08-04 19:00","pubTimestamp":1785841201,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260804:nPLX77K9ZM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["FBT","LU0757428866.USD","TINY","BRKR","BK4121","LU1815336091.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656305355","title":"Bruker Q2 Gross Profit USD 416 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2656305355","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656305355?lang=en_us&edition=fundamental","pubTime":"2026-08-04 19:00","pubTimestamp":1785841201,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260804:nPLX77K9ZM:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["FBT","BK4121","TINY","LU0757428866.USD","LU1815336091.USD","BRKR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656300056","title":"Alkermes EVP, CLO David Joseph Gaffin Sells 2,034 Shares for $98,821.72","url":"https://stock-news.laohu8.com/highlight/detail?id=2656300056","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656300056?lang=en_us&edition=fundamental","pubTime":"2026-08-04 07:10","pubTimestamp":1785798604,"startTime":"0","endTime":"0","summary":"Alkermes EVP, CLO David Joseph Gaffin sells 2,034 shares for $98,821.72David Joseph Gaffin, EVP and chief legal officer, sold 2,034 ordinary shares on Aug. 3, 2026 at USD 48.58.His direct stake fell t","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nNDL9zXC08:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Alkermes EVP, CLO David Joseph Gaffin Sells 2,034 Shares for $98,821.72","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PSIL","MEDX","BK4139","ALKS","PSCH","IBRN","FBT"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":9,"totalSize":200,"code":"91000000","status":"200"}]}}